Editorial: The molecular mechanisms and therapeutic implications of protein kinase inhibitors in cancer therapy
Yu-Hong Sun et al · Frontiers Media S.A · 2026
A combined model of BCVA, TRAb, and NLR predicts response to intravenous methylprednisolone in dysthyroid optic neuropathy
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso abierto disponible
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, Y. H. S. E. (2026). Editorial: The molecular mechanisms and therapeutic implications of protein kinase inhibitors in cancer therapy. https://doi.org/10.3389/fmed.2026.1853424
MLA
al, Yu-Hong Sun et. "Editorial: The molecular mechanisms and therapeutic implications of protein kinase inhibitors in cancer therapy." 2026. https://doi.org/10.3389/fmed.2026.1853424.
Chicago
al, Yu-Hong Sun et. 2026. "Editorial: The molecular mechanisms and therapeutic implications of protein kinase inhibitors in cancer therapy.". https://doi.org/10.3389/fmed.2026.1853424.
Harvard
al, Y. H. S. E. 2026, Editorial: The molecular mechanisms and therapeutic implications of protein kinase inhibitors in cancer therapy, Frontiers Media S.A, available at: https://doi.org/10.3389/fmed.2026.1853424 [Accessed 29 Jun. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- Editorial: The molecular mechanisms and therapeutic implications of protein kinase inhibitors in cancer therapy
- Autor / colaboradores
- Yu-Hong Sun et al
- Editorial
- Frontiers Media S.A
- Año de publicación
- 2026
- ISSN
- 2296-858X
- ISSN
- 2296-858X
- Idioma
- eng
Materias
Explorá otros recursos relacionados a partir de estas materias.